CD86 and breast carcinoma: further showed that TAMs with high NRP2 expression, isolated from 4T1-derived murine breast cancer models, co-expressed both CD86 and CD206, whereas TAMs with low NRP2 expression were predominantly associated with high CD86 expression only (48).